MedPath

Effects of AmLexin (Acacia Catechu and Morus Alba) on Redox and Subjective Pain in Healthy Physically Active Adults

Not Applicable
Completed
Conditions
Pain, stiffness, range of motion, psychological mood state (wellbeing, mood, vigor) and cellular oxidation
Not Applicable
Pain Stiffness Range of motion Psychological mood state (wellbeing, mood, vigor) Cellular oxidation
Registration Number
ISRCTN10377494
Lead Sponsor
nigen Inc.
Brief Summary

2018 Results article in https://pubmed.ncbi.nlm.nih.gov/30661328/ (added 07/12/2021)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
30
Inclusion Criteria

1. Aged 18-70
2. BMI < 30 kg/m²
3. Healthy and active
4. No recurrent pain or limitations in range of motion
5. Ability to complete training for, and complete, a 13.1 mile half-marathon run
6. Willing to consume dietary supplements under investigation
7. Willing to undertake all protocol measurements and training regimens
8. Ability to understand and sign the informed consent form

Exclusion Criteria

1. Recurrent pain, use of pain medications or pain supplements
2. Pregnant or breastfeeding women
3. Inability to complete prescribed training regimen
4. Current use of other pain support supplement or over-the-counter drug

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<br> The following are assessed at the baseline, weekly during the training regimen (weeks 1, 2, 3, 4, 5, 6, 7 and 8), and daily for a week post half-marathon:<br> 1. Range of motions (ROM), assessed using digital inclinometry<br> 2. Pain, stiffness and activities of daily living, assessed using a visual analogue scale (VAS) and the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)<br>
Secondary Outcome Measures
NameTimeMethod
<br> 1. Oxidation-reduction potential (ORP), assessed using the Luoxis' proprietary RedoxSYS Diagnostic System at the baseline and 7 days post-marathon<br> 2. Profile of mood states, assessed using the Profile of Mood States Survey (POMS) at the baseline and 1 and 7 days post-marathon<br>
© Copyright 2025. All Rights Reserved by MedPath